Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Evaluation and cost analysis of national health policy of thalassaemia screening in west-azerbaijan province of iran.

Ahmadnezhad E, Sepehrvand N, Jahani FF, Hatami S, Kargar C, Mirmohammadkhani M, Bazargan-Hejazi S.

Int J Prev Med. 2012 Oct;3(10):687-92.

2.

Evaluation of the national health policy of thalassaemia screening in the Islamic Republic of Iran.

Ghotbi N, Tsukatani T.

East Mediterr Health J. 2005 May;11(3):308-18.

PMID:
16602449
3.

Premarital screening for beta-thalassaemia in Southern Iran: options for improving the programme.

Karimi M, Jamalian N, Yarmohammadi H, Askarnejad A, Afrasiabi A, Hashemi A.

J Med Screen. 2007;14(2):62-6.

PMID:
17626703
4.

Sociocultural challenges of beta-thalassaemia major birth in carriers of beta-thalassaemia in Iran.

Haghpanah S, Nasirabadi S, Rahimi N, Faramarzi H, Karimi M.

J Med Screen. 2012 Sep;19(3):109-11. doi: 10.1258/jms.2012.012038.

PMID:
23093727
5.

Pre-marriage prevention of thalassaemia: report of a 100,000 case experience in Isfahan.

Ghanei M, Adibi P, Movahedi M, Khami MA, Ghasemi RL, Azarm T, Zolfaghari B, Jamshidi HR, Sadri R.

Public Health. 1997 May;111(3):153-6.

PMID:
9175458
6.

Results of the national program for prevention of beta-thalassemia major in the Iranian Province of Mazandaran.

Khorasani G, Kosaryan M, Vahidshahi K, Shakeri S, Nasehi MM.

Hemoglobin. 2008;32(3):263-71. doi: 10.1080/03630260802004269.

PMID:
18473242
7.

Cost-effectiveness of prenatal screening for thalassaemia in Hong Kong.

Leung KY, Lee CP, Tang MH, Lau ET, Ng LK, Lee YP, Chan HY, Ma ES, Chan V.

Prenat Diagn. 2004 Nov;24(11):899-907.

PMID:
15565640
8.
9.

[Large-scale population-based genetic screening and prenatal diagnosis for thalassemias in Zhuhai City of Guangdong Province].

Zhou YQ, Shang X, Yin BM, Xiong F, Xiao QZ, Zhou WJ, Zhang YL, Xu XM.

Zhonghua Fu Chan Ke Za Zhi. 2012 Feb;47(2):90-5. Chinese.

PMID:
22455738
10.

Genetic Blood Disorders Survey in the Sultanate of Oman.

Al-Riyami A, Ebrahim GJ.

J Trop Pediatr. 2003 Jul;49 Suppl 1:i1-20.

PMID:
12934793
11.

Evaluation of the national prevention program in iran, 2007-2009: the accomplishments and challenges with reflections on the path ahead.

Hadipour Dehshal M, Tabrizi Namini M, Ahmadvand A, Manshadi M, Sadeghian Varnosfaderani F, Abolghasemi H.

Hemoglobin. 2014;38(3):179-87. doi: 10.3109/03630269.2014.893530. Epub 2014 Mar 26.

PMID:
24669933
12.
13.

Premarital Screening of Beta Thalassemia Minor in north-east of Iran.

Hashemizadeh H, Noori R.

Iran J Ped Hematol Oncol. 2013;3(1):210-5. Epub 2013 Jan 22.

14.

Psychosocial burden of beta-thalassaemia major in Antalya, south Turkey.

Canatan D, Ratip S, Kaptan S, Cosan R.

Soc Sci Med. 2003 Feb;56(4):815-9.

PMID:
12560014
15.

Cost-benefit analysis of a thalassemia disease prevention program.

Ostrowsky JT, Lippman A, Scriver CR.

Am J Public Health. 1985 Jul;75(7):732-6.

16.
17.

Thalassaemia in Azerbaijan.

Kuliev AM, Rasulov IM, Dadasheva T, Schwarz EI, Rosatelli C, Saba L, Meloni A, Gemidjioglu E, Petrou M, Modell B.

J Med Genet. 1994 Mar;31(3):209-12.

18.

Premarital screening of beta-thalassemia trait in the province of Denizli, Turkey.

Keskin A, Türk T, Polat A, Koyuncu H, Saracoglu B.

Acta Haematol. 2000;104(1):31-3.

PMID:
11111119
19.

Cost-benefit analysis of a national thalassaemia prevention programme in Israel.

Ginsberg G, Tulchinsky T, Filon D, Goldfarb A, Abramov L, Rachmilevitz EA.

J Med Screen. 1998;5(3):120-6.

PMID:
9795870
20.

Beta-thalassaemia carrier detection by ELISA: a simple screening strategy for developing countries.

Ravindran MS, Patel ZM, Khatkhatay MI, Dandekar SP.

J Clin Lab Anal. 2005;19(1):22-5.

PMID:
15645468
Items per page

Supplemental Content

Write to the Help Desk